DOCSLIB.ORG

A Nociceptinerg Rendszer Változása Hepatológiai Kórképekben, Különös

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
A Nociceptinerg Rendszer Változása Hepatológiai Kórképekben, Különös Recovery of new diarylheptanoid sources in Betulaceae Characterisation of the phenolic profile of Corylus species by HPLC-ESI-MS methods Ph.D. Dissertation Eszter Riethmüller Semmelweis University Doctoral School of Pharmaceutical Sciences Supervisor: Dr. Ágnes Kéry, Ph.D. Reviewers: Dr. Gergely Völgyi Ph.D. Dr. Attila Hunyadi Ph.D. Chair of final examination committee: Dr. Éva Lemberkovics Ph.D. Members of final examination committee: Dr. Huba Kalász D.Sc. Dr. Imre Máthé D.Sc. Budapest 2016 TABLE OF CONTENTS TABLE OF CONTENTS ......................................................................................................... 2 1. LIST OF ABBREVIATIONS ............................................................................................... 6 2. INTRODUCTION ............................................................................................................. 8 2.1. Structural features and biosynthesis of diarylheptanoids ............................. 10 2.2. Distribution of diarylheptanoids in the plant kingdom................................. 12 2.3. Biological activities of diarylheptanoids ...................................................... 14 2.3.1. Curcuma genus (Zingiberaceae)................................................................... 14 2.3.1.1. Structural features and bioavailability of curcumin ..................................... 16 2.3.1.2. Antioxidant activity of curcumin.................................................................. 16 2.3.1.3. Anti-inflammatory effect of curcumin ......................................................... 17 2.3.1.4. Anti-tumoural properties of curcumin .......................................................... 19 2.3.1.5. The positive effects of curcumin in neurodegenerative diseases ................. 20 2.3.1.6. The dark side of curcumin ............................................................................ 21 2.3.2. Alpinia genus (Zingiberaceae)...................................................................... 22 2.3.2.1. Effect on neuronal differentiation ................................................................ 23 2.3.2.2. Selective cytotoxic effect ............................................................................. 23 2.3.2.3. Antibacterial effect ....................................................................................... 24 2.3.2.4. Platelet-activating factor receptor binding inhibitory activity...................... 24 2.3.2.5. Anti-angiogenic activity ............................................................................... 24 2.3.2.6. Anti-inflammatory activity ........................................................................... 25 2.3.3. Morella and Myrica genera (Myricaceae) .................................................... 25 2.3.3.1. Antioxidant activity ...................................................................................... 25 2.3.3.2. Anti-inflammatory activity ........................................................................... 26 2.3.3.3. Anticancer activity........................................................................................ 26 2.3.3.4. Positive effect in neurodegenerative diseases .............................................. 27 2.3.4. Acer genus (Aceraceae) ................................................................................ 27 2.3.4.1. Anti-inflammatory effect .............................................................................. 27 2.3.4.2. Effect on osteoblast differentiation .............................................................. 27 2 2.3.4.3. Anti-diabetic effect ....................................................................................... 28 2.3.5. Juglans genus (Juglandaceae) ...................................................................... 28 2.3.5.1. Neuroprotective and antioxidant effect ........................................................ 28 2.3.6. Alnus genus (Betulaceae) ............................................................................. 29 2.3.6.1. Antioxidant activity ...................................................................................... 29 2.3.6.2. Anticancer activity........................................................................................ 30 2.3.6.3. Anti-inflammatory activity ........................................................................... 31 2.3.6.4. Immunosuppressive activity ......................................................................... 31 2.3.6.5. Other effects ................................................................................................. 32 2.3.7. Betula genus (Betulaceae) ............................................................................ 32 2.3.7.1. Antifibrotic activity ...................................................................................... 32 2.3.7.2. Selective cytotoxic activity........................................................................... 33 2.4. Corylus avellana L. (Common hazel, Betulaceae)....................................... 33 2.4.1. Ethimology ................................................................................................... 33 2.4.2. Taxonomic classification .............................................................................. 33 2.4.3. Morphology .................................................................................................. 34 2.4.4. Traditional use .............................................................................................. 34 2.4.5. Pharmacological effects................................................................................ 35 2.4.6. Phytochemical characterisation .................................................................... 36 2.5. Corylus colurna L. (Turkish hazel, Betulaceae) .......................................... 37 2.5.1. Morphology .................................................................................................. 37 2.5.2. Traditional use .............................................................................................. 38 2.5.3. Pharmacological effects................................................................................ 38 2.5.4. Phytochemical characterisation .................................................................... 39 2.6. Corylus maxima Mill. (Filbert, Betulaceae) ................................................. 39 2.6.1. Ethymology .................................................................................................. 39 2.6.2. Morphology .................................................................................................. 39 2.6.3. Traditional use .............................................................................................. 40 2.6.4. Phytochemical characterisation .................................................................... 40 3. OBJECTIVES ................................................................................................................ 41 4. MATERIALS AND METHODS ......................................................................................... 43 4.1. Plant material ................................................................................................ 43 3 4.2. Solvents and chemicals................................................................................. 43 4.3. Extraction and sample preparation ............................................................... 44 4.4. Quantitative phytochemical analyses ........................................................... 44 4.5. Antioxidant activity assays ........................................................................... 44 4.6. Characterisation of phenolics in the Corylus extracts by HPLC-DAD-MS . 45 4.6.1. HPLC-DAD-QMS conditions ...................................................................... 45 4.6.2. HPLC-DAD-TOF-MS conditions ................................................................ 46 4.6.3. HPLC-DAD-MS/MS conditions .................................................................. 48 4.7. Quantitative analyses by HPLC-MS/MS...................................................... 49 4.7.1. Determination of diarylheptanoids ............................................................... 49 4.7.2. Determination of flavonoids ......................................................................... 49 4.7.3. Method validation – Calibration, precision, accuracy and quality control .. 50 4.8. HPLC-based DPPH scavenging assay.......................................................... 51 4.8.1. Sample preparation ....................................................................................... 51 5. RESULTS ..................................................................................................................... 52 5.1. Quantitative phytochemical analyses ........................................................... 52 5.2. Antioxidant activity assays ........................................................................... 52 5.2.1. Scavenging activity on DPPH free radical ................................................... 53 5.2.2. Scavenging activity on ABTS free radical ................................................... 54 5.3. Characterisation of phenolics in the Corylus extracts by HPLC-MS ........... 55 5.3.1. Corylus avellana L. ...................................................................................... 56 5.3.2. Corylus colurna L........................................................................................
Load more

Recommended publications
  • Cornus Canadensis Serge Lavoie, Isabelle Côté, André Pichette, Charles Gauthier, Michaël Ouellet, Francine Nagau-Lavoie, Vakhtang Mshvildadze, Jean Legault
    Chemical composition and anti-herpes simplex virus type 1 (HSV-1) activity of extracts from Cornus canadensis Serge Lavoie, Isabelle Côté, André Pichette, Charles Gauthier, Michaël Ouellet, Francine Nagau-Lavoie, Vakhtang Mshvildadze, Jean Legault To cite this version: Serge Lavoie, Isabelle Côté, André Pichette, Charles Gauthier, Michaël Ouellet, et al.. Chem- ical composition and anti-herpes simplex virus type 1 (HSV-1) activity of extracts from Cornus canadensis. BMC Complementary and Alternative Medicine, BioMed Central, 2017, 17 (1), pp.123. 10.1186/s12906-017-1618-2. pasteur-01534565 HAL Id: pasteur-01534565 https://hal-riip.archives-ouvertes.fr/pasteur-01534565 Submitted on 7 Jun 2017 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Distributed under a Creative Commons Attribution - NonCommercial - ShareAlike| 4.0 International License Lavoie et al. BMC Complementary and Alternative Medicine (2017) 17:123 DOI 10.1186/s12906-017-1618-2 RESEARCH ARTICLE Open Access Chemical composition and anti-herpes simplex virus type 1 (HSV-1) activity of extracts from Cornus canadensis Serge Lavoie1, Isabelle Côté1, André Pichette1, Charles Gauthier1,2, Michaël Ouellet1, Francine Nagau-Lavoie1, Vakhtang Mshvildadze1 and Jean Legault1* Abstract Background: Many plants of boreal forest of Quebec have been used by Native Americans to treat a variety of microbial infections.
    [Show full text]
  • Phytochemical Analysis and Antimicrobial Activity of Myrcia Tomentosa (Aubl.) DC
    molecules Article Phytochemical Analysis and Antimicrobial Activity of Myrcia tomentosa (Aubl.) DC. Leaves Fabyola Amaral da Silva Sa 1,3, Joelma Abadia Marciano de Paula 2, Pierre Alexandre dos Santos 3, Leandra de Almeida Ribeiro Oliveira 3, Gerlon de Almeida Ribeiro Oliveira 4, Luciano Morais Liao 4 , Jose Realino de Paula 3,* and Maria do Rosario Rodrigues Silva 1,* 1 Institute of Tropical Pathology and Public Health, Federal University of Goias, Goiânia 74605-050, Brazil; [email protected] 2 Unit of Exact and Technologic Sciences, Goias State University, Anápolis 75132-400, Brazil; [email protected] 3 Faculty of Pharmacy, Federal University of Goias, Goiânia 74605-170, Brazil; [email protected] (P.A.d.S.); [email protected] (L.d.A.R.O.) 4 Chemistry Institute, Federal University of Goiás, Goiânia 74690-900, Brazil; [email protected] (G.d.A.R.O.); [email protected] (L.M.L.) * Correspondence: [email protected] (J.R.d.P.); [email protected] (M.d.R.R.S.); Tel.: +55-62-3209-6127 (M.d.R.R.S.); Fax: +55-62-3209-6363 (M.d.R.R.S.) Academic Editor: Isabel C. F. R. Ferreira Received: 23 May 2017; Accepted: 29 June 2017; Published: 4 July 2017 Abstract: This work describes the isolation and structural elucidation of compounds from the leaves of Myrcia tomentosa (Aubl.) DC. (goiaba-brava) and evaluates the antimicrobial activity of the crude extract, fractions and isolated compounds against bacteria and fungi. Column chromatography was used to fractionate and purify the extract of the M. tomentosa leaves and the chemical structures of the compounds were determined using spectroscopic techniques.
    [Show full text]
  • Fighting Bisphenol A-Induced Male Infertility: the Power of Antioxidants
    antioxidants Review Fighting Bisphenol A-Induced Male Infertility: The Power of Antioxidants Joana Santiago 1 , Joana V. Silva 1,2,3 , Manuel A. S. Santos 1 and Margarida Fardilha 1,* 1 Department of Medical Sciences, Institute of Biomedicine-iBiMED, University of Aveiro, 3810-193 Aveiro, Portugal; [email protected] (J.S.); [email protected] (J.V.S.); [email protected] (M.A.S.S.) 2 Institute for Innovation and Health Research (I3S), University of Porto, 4200-135 Porto, Portugal 3 Unit for Multidisciplinary Research in Biomedicine, Institute of Biomedical Sciences Abel Salazar, University of Porto, 4050-313 Porto, Portugal * Correspondence: [email protected]; Tel.: +351-234-247-240 Abstract: Bisphenol A (BPA), a well-known endocrine disruptor present in epoxy resins and poly- carbonate plastics, negatively disturbs the male reproductive system affecting male fertility. In vivo studies showed that BPA exposure has deleterious effects on spermatogenesis by disturbing the hypothalamic–pituitary–gonadal axis and inducing oxidative stress in testis. This compound seems to disrupt hormone signalling even at low concentrations, modifying the levels of inhibin B, oestra- diol, and testosterone. The adverse effects on seminal parameters are mainly supported by studies based on urinary BPA concentration, showing a negative association between BPA levels and sperm concentration, motility, and sperm DNA damage. Recent studies explored potential approaches to treat or prevent BPA-induced testicular toxicity and male infertility. Since the effect of BPA on testicular cells and spermatozoa is associated with an increased production of reactive oxygen species, most of the pharmacological approaches are based on the use of natural or synthetic antioxidants.
    [Show full text]
  • The Phytochemistry of Cherokee Aromatic Medicinal Plants
    medicines Review The Phytochemistry of Cherokee Aromatic Medicinal Plants William N. Setzer 1,2 1 Department of Chemistry, University of Alabama in Huntsville, Huntsville, AL 35899, USA; [email protected]; Tel.: +1-256-824-6519 2 Aromatic Plant Research Center, 230 N 1200 E, Suite 102, Lehi, UT 84043, USA Received: 25 October 2018; Accepted: 8 November 2018; Published: 12 November 2018 Abstract: Background: Native Americans have had a rich ethnobotanical heritage for treating diseases, ailments, and injuries. Cherokee traditional medicine has provided numerous aromatic and medicinal plants that not only were used by the Cherokee people, but were also adopted for use by European settlers in North America. Methods: The aim of this review was to examine the Cherokee ethnobotanical literature and the published phytochemical investigations on Cherokee medicinal plants and to correlate phytochemical constituents with traditional uses and biological activities. Results: Several Cherokee medicinal plants are still in use today as herbal medicines, including, for example, yarrow (Achillea millefolium), black cohosh (Cimicifuga racemosa), American ginseng (Panax quinquefolius), and blue skullcap (Scutellaria lateriflora). This review presents a summary of the traditional uses, phytochemical constituents, and biological activities of Cherokee aromatic and medicinal plants. Conclusions: The list is not complete, however, as there is still much work needed in phytochemical investigation and pharmacological evaluation of many traditional herbal medicines. Keywords: Cherokee; Native American; traditional herbal medicine; chemical constituents; pharmacology 1. Introduction Natural products have been an important source of medicinal agents throughout history and modern medicine continues to rely on traditional knowledge for treatment of human maladies [1]. Traditional medicines such as Traditional Chinese Medicine [2], Ayurvedic [3], and medicinal plants from Latin America [4] have proven to be rich resources of biologically active compounds and potential new drugs.
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 7,399,783 B2 Rosenbloom (45) Date of Patent: Jul
    US007399.783B2 (12) United States Patent (10) Patent No.: US 7,399,783 B2 Rosenbloom (45) Date of Patent: Jul. 15, 2008 (54) METHODS FOR THE TREATMENT OF SCAR Quercetin: Implications for the Treatment of Excessive Scars.” TSSUE Internet Web Page, vol. 57(5); Nov. 2004. Marilyn Sterling, R.D., Article: Science Beat, Internet Web Page, (75) Inventor: Richard A. Rosenbloom, Elkins Park, Natural Foods Merchandiser vol. XXIV, No. 10, p. 50, 2003. PA (US) Phan TT. See P. Tran E. Nguyen TT, Chan SY. Lee ST and Huynh H., PubMed, Internet Web Page, “Suppression of Insulin-like Growth (73) Assignee: The Quigley Corporation, Doylestown, Factor Signalling Pathway and Collagen Expression in Keloid-De rived Fibroblasts by Quercetin: It's Therapeutic Potential Use in the PA (US) Treatment and/or Prevention of Keloids.” Br. J. Dermatol., Mar. 2003, 148(3):544-52. (*) Notice: Subject to any disclaimer, the term of this Crystal Smith, Kevin A. Lombard, Ellen B. Peffley and Weixin Liu; patent is extended or adjusted under 35 "Genetic Analysis of Quercetin in Onion (Allium cepa L.) Lady U.S.C. 154(b) by 440 days. Raider.” The Texas Journal of Agriculture and Natural Resource, vol. 16 pp. 24-28, 2003. (21) Appl. No.: 11/158,986 Skin Actives Scientific L.L.C., Internet Web Page, “Quercetin.” Quercetin by Skinactives, printed on Apr. 10, 2006. (22) Filed: Jun. 22, 2005 Saulis, Alexandrina S. M.D.; Mogford, Jon H. Ph.D.; Mustoe, Tho mas A., M.D., Plastic and Reconstructive Surgery, “Effect of (65) Prior Publication Data Mederma on Hypertrophic Scarring in the Rabbit Ear Model.” Jour US 2006/O293257 A1 Dec.
    [Show full text]
  • WO 2018/002916 Al O
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2018/002916 Al 04 January 2018 (04.01.2018) W !P O PCT (51) International Patent Classification: (81) Designated States (unless otherwise indicated, for every C08F2/32 (2006.01) C08J 9/00 (2006.01) kind of national protection available): AE, AG, AL, AM, C08G 18/08 (2006.01) AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, (21) International Application Number: DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, PCT/IL20 17/050706 HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, (22) International Filing Date: KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, 26 June 2017 (26.06.2017) MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, (25) Filing Language: English SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, (26) Publication Language: English TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (30) Priority Data: (84) Designated States (unless otherwise indicated, for every 246468 26 June 2016 (26.06.2016) IL kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, (71) Applicant: TECHNION RESEARCH & DEVEL¬ UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, OPMENT FOUNDATION LIMITED [IL/IL]; Senate TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, House, Technion City, 3200004 Haifa (IL).
    [Show full text]
  • Dr. Duke's Phytochemical and Ethnobotanical Databases List of Chemicals for Cataracts
    Dr. Duke's Phytochemical and Ethnobotanical Databases List of Chemicals for Cataracts Chemical Activity Count (+)-ALPHA-VINIFERIN 2 (+)-CATECHIN 5 (+)-CORYDALINE 1 (+)-EUDESMA-4(14),7(11)-DIENE-3-ONE 1 (+)-GALLOCATECHIN 1 (+)-GLAUCINE 1 (+)-HERNANDEZINE 1 (+)-ISOCORYDINE 1 (+)-PSEUDOEPHEDRINE 1 (+)-SYRINGARESINOL 1 (+)-SYRINGARESINOL-DI-O-BETA-D-GLUCOSIDE 1 (-)-16,17-DIHYDROXY-16BETA-KAURAN-19-OIC 1 (-)-ALPHA-BISABOLOL 1 (-)-BETONICINE 1 (-)-BISPARTHENOLIDINE 1 (-)-BORNYL-CAFFEATE 2 (-)-BORNYL-FERULATE 2 (-)-BORNYL-P-COUMARATE 2 (-)-DANSHEXINKUN 1 (-)-EPIAFZELECHIN 1 (-)-EPICATECHIN 3 (-)-EPICATECHIN-3-O-GALLATE 1 (-)-EPIGALLOCATECHIN 2 (-)-EPIGALLOCATECHIN-3-O-GALLATE 1 (-)-EPIGALLOCATECHIN-GALLATE 4 (-)-HYDROXYJASMONIC-ACID 1 (-)-STYLOPINE 1 Chemical Activity Count (-)-TETRAHYDROCOLUMBAMINE 1 (1'S)-1'-ACETOXYCHAVICOL-ACETATE 2 (15:1)-CARDANOL 1 (2R)-(12Z,15Z)-2-HYDROXY-4-OXOHENEICOSA-12,15-DIEN-1-YL-ACETATE 1 (3'R,4'R)-3'-EPOXYANGELOYLOXY-4'-ACETOXY-3',4'-DIHYDROSESELIN 1 (7R,10R)-CAROTA-1,4-DIENALDEHYDE 1 (E)-4-(3',4'-DIMETHOXYPHENYL)-BUT-3-EN-OL 2 1,2,3,6-TETRA-O-GALLYOL-BETA-D-GLUCOSE 1 1,2,6-TRI-O-GALLOYL-BETA-D-GLUCOSE 1 1,3,6-TRIHYDROXY-2,7-DIMETHOXY-XANTHONE 1 1,6,7-TRIHYDROXY-2,3-DIMETHOXY-XANTHONE 1 1,7-BIS(3,4-DIHYDROXYPHENYL)HEPTA-4E,6E-DIEN-3-ONE 1 1,7-BIS-(4-HYDROXYPHENYL)-1,4,6-HEPTATRIEN-3-ONE 1 1,8-CINEOLE 3 1-HYDROXY-3,6,7-TRIMETHOXY-XANTHONE 1 1-METHOXY-2,3-METHYLENEDIOXY-XANTHONE 1 1-O-(2,3,4-TRIHYDROXY-3-METHYL)-BUTYL-6-O-FERULOYL-BETA-D-GLUCOPYRANOSIDE 1 10-ACETOXY-8-HYDROXY-9-ISOBUTYLOXY-6-METHOXYTHYMOL 2 10-DEHYDROGINGERDIONE
    [Show full text]
  • Identification of Multiple Constituents in Shuganjieyu Capsule and Rat
    Original Research Paper Identification of Multiple Constituents in Shuganjieyu Capsule and Rat Plasma after Oral Administration by Ultra-Performance Liquid Chromatography Coupled with Electrospray Ionization and Ion Trap Mass Spectrometry Y. C. Xiao, L. T. Liu, J. J. Bian, C. Q. Yan, L. Ye, M. X. Zhao, Q. S. Huang, W. Wang, K. Liang, Z. F. Shi and X. Ke* Chengdu Kanghong Pharmaceutical Co. Ltd., Chengdu, Sichuan 610036, P.R. China Received: 06 August 2016; accepted: 18 October 2016 Shuganjieyu (SGJY) capsule is a classical formula widely used in Chinese clinical application. In this paper, an ultra- performance liquid chromatography coupled with electrospray ionization and ion trap mass spectrometry has been established to separate and identify the chemical constituents of SGJY and the multiple constituents of SGJY in rats. The chromatographic separation was performed on a C18 RRHD column (150 × 2.1 mm, 1.8 μm), while 0.1% formic acid–water and 0.1% formic acid–acetonitrile was used as mobile phase. Mass spectral data were acquired in both positive and negative modes. On the basis of the characteristic retention time (Rt) and mass spectral data with those of reference standards and relevant references, 73 constituents from the SGJY and 15 ingredients including 10 original constituents and 5 metabolites from the rat plasma after oral administration of SGJY were identified or tentatively characterized. This study provided helpful chemical information for further pharmacology and active mechanism re- search on SGJY. Keywords: Constituents, rat plasma, UHPLC–ESI–MS/MS, Shuganjieyu capsule 1. Introduction S150102) were offered by Chengdu Kanghong Pharmaceutical Co.
    [Show full text]
  • Identification of Antioxidative Constituents from Polygonum Aviculare Using LC-MS Coupled with DPPH Assay
    Natural Product Sciences 22(1) : 64-69 (2016) http://dx.doi.org/10.20307/nps.2016.22.1.64 Identification of Antioxidative Constituents from Polygonum aviculare using LC-MS Coupled with DPPH Assay Hyeji Shin1, Hayeon Chung1, Byoungduck Park2 and Ki Yong Lee1,* 1College of Pharmacy, Korea University, Sejong 339-700, Korea 2College of Pharmacy, Keimyung University, Daegu 704-701, Korea Abstract − A method for simultaneously identifying antioxidative compounds was developed using time-based LC-MS coupled with DPPH assay regardless of the time consuming process. The methanolic extract of Polygonum aviculare (Polygonaceae) showed significant DPPH radical scavenging activity. Time-based DPPH assay for simultaneous identification of active compounds from the extracts of P. aviculare was used. Major peaks of ethyl acetate fraction of P. aviculare showed high DPPH radical scavenging activity. A simple phenolic compound (1) and six flavonoids (2-7) were isolated from the ethyl acetate fraction of P. aviculare by silica gel and sephadex LH-20 column chromatography. The structures of seven compounds were determined to be protocatechuic acid (1), catechin (2), myricitrin (3), epicatechin-3-O-gallate (4), avicularin (5), quercitrin (6), and juglanin (7) based on the analysis of the 1H-NMR, 13C-NMR and ESI-MS data. All compounds exhibited significant antioxidant activity on DPPH assay and active compounds were well correlated with predicted one. Keywords − Polygonum aviculare, Flavonoids, LC-MS, DPPH assay Introduction important traditional medicine to treat rheumatitis, gout, diarrhea, dysentery, hemoptysis and bleeding.5 A previous Natural products which have used for thousands of study have been reported flavonoids (quercetin, kaempferol, years have showed different therapeutic effects with few myricetin, isorhamnetin, luteolin, avicularin, myricitrin, side effects by pharmacological studies and clinical trials.
    [Show full text]
  • Flavone and Flavonol Glycosides from the Leaves of Triumfetta Procumbens in Ryukyu Islands
    Bull. Natl. Mus. Nat. Sci., Ser. B, 38(2), pp. 63–67, May 22, 2012 Flavone and Flavonol Glycosides from the Leaves of Triumfetta procumbens in Ryukyu Islands Tsukasa Iwashina* and Goro Kokubugata Department of Botany, National Museum of Nature and Science, 4–1–1 Amakubo, Tsukuba, Ibaraki 305–0005, Japan * E-mail: [email protected] (Received 11 February 2012; accepted 28 March 2012) Abstract Four flavonoids were isolated from the leaves of Triumfetta procumbens in Ryukyu Islands for the first time. They were identified as apigenin 7-O-glucuronide, luteolin 7-O-glucuro- nide, schaftoside and kaempferol 3-O-(p-coumaroylglucoside) by UV, LC-MS, acid hydrolysis, and direct TLC and HPLC comparisons with authentic samples. From the species belonging to the family Tiliaceae sensu stricto including the genus Triumfetta, some flavonols and flavones have been found together with a few dihydroflavonols and proanthocyanidins. However, three flavonoid O-glycosides and C-glycoside except for kaempferol 3-O-(p-coumaroylglucoside), which were isolated in this experiment, were reported from the family Tiliaceae s.s. for the first time. Key words : apigenin and luteolin 7-glucuronides, flavonoids, kaempferol 3-(p-coumaroylgluco- side), schaftoside, Tiliaceae s.s., Triumfetta. 7-O-rhamnosylarabinoside and scutellarein Introduction 7-O-rhamnoside, respectively (Srinivasan and The genus Triumfetta belongs to the family Subramanian, 1981), chemical structure of trium- Tiliaceae, which was recently included in the boidin was later revised as scutellarein 6-O-β-D- family Malvaceae together with Bombacaceae xyloside-7-O-α-L-rhamnopyranoside by 1H and and Sterculiaceae by APG. The genus consists of 13C NMR and FAB-MS methods (Nair et al., ca.
    [Show full text]
  • Antioxidative and Antiaging Activities and Component Analysis of Lespedeza Cuneata G
    J. Microbiol. Biotechnol. (2017), 27(11), 1961–1970 https://doi.org/10.4014/jmb.1706.06028 Research Article Review jmb Antioxidative and Antiaging Activities and Component Analysis of Lespedeza cuneata G. Don Extracts Fermented with Lactobacillus pentosus S Joon Seob Seong, Song Hua Xuan, So Hyun Park, Keon Soo Lee, Young Min Park, and Soo Nam Park1* Department of Fine Chemistry, Cosmetic R&D Center, Cosmetic Industry Coupled Collaboration Center, Seoul National University of Science and Technology, Seoul 01811, Republic of Korea Received: June 12, 2017 Revised: September 6, 2017 Lespedeza cuneata G. Don is a traditional herb that has been associated with multiple biological Accepted: September 14, 2017 activities. In this study, we investigated the antioxidative/antiaging activities and performed First published online an active component analysis of the non-fermented and fermented (using Lactobacillus September 15, 2017 pentosus) extracts of Lespedeza cuneata G. Don. The antioxidative activities of the fermented *Corresponding author extract were higher than those of non-fermented extracts. The elastase inhibitory activity, Phone: +82-2-970-6451; inhibitory effects on UV-induced MMP-1 expression, and ability to promote type I procollagen Fax: +82-2-972-9585; E-mail: [email protected] synthesis were investigated in Hs68 human fibroblasts cells. These tests also revealed that the fermented extract had increased antiaging activities compared with the non-fermented extract. A component analysis of the ethyl acetate fractions of non-fermented and fermented extracts was performed using TLC, HPLC, and LC/ESI-MS/MS to observe changes in the components before and after fermentation. Six components that were different before and after fermentation were investigated.
    [Show full text]
  • Downloaded 9/25/2021 1:20:38 PM
    RSC Advances View Article Online REVIEW View Journal | View Issue Nature as a treasure trove of potential anti-SARS- CoV drug leads: a structural/mechanistic rationale† Cite this: RSC Adv., 2020, 10, 19790 Ahmed M. Sayed,a Amira R. Khattab,b Asmaa M. AboulMagd, c Hossam M. Hassan, de Mostafa E. Rateb,f Hala Zaidg and Usama Ramadan Abdelmohsen *hi The novel Coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 is a potential factor for fatal illness and a tremendous concern for global public health. The COVID-19 pandemic has entered a dangerous new phase. In the context of drug discovery, the structurally-unique and chemically-diverse natural products have been valuable sources for drug leads. In this review, we report for potential candidates derived from natural sources with well-reported in vitro efficacy against SARS-CoV during the last decade. Additionally, a library of 496 phenolic metabolites was subjected to a computer-aided virtual screening against the active site of the recently reported SARS-CoV Main protease (Mpro). Analysis of physicochemical properties of these natural products has been carried out and presented for all the Creative Commons Attribution-NonCommercial 3.0 Unported Licence. tested phenolic metabolites. Only three of the top candidates, viz. acetylglucopetunidin (31), Received 11th May 2020 isoxanthohumol (32) and ellagic acid (33), which are widely available in many edible fruits, obey both Accepted 21st May 2020 Lipinski's and Veber's rules of drug-likeness and thus possess high degrees of predicted bioavailability. DOI: 10.1039/d0ra04199h These natural products are suggested as potential drug candidates for the development of anti-SARS- rsc.li/rsc-advances CoV-2 therapeutics in the near future.
    [Show full text]